Join the Aimovig group to help and get support from people like you.
Aimovig News
Erenumab Effective for Nonopioid Medication Overuse Headache in Chronic Migraine
WEDNESDAY, Sept. 18, 2024 – Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH) remission in patients with nonopioid chronic migraine...
FDA Approves Aimovig (erenumab-aooe) as a Preventive Treatment for Migraine
May 17, 2018 – The U.S. Food and Drug Administration today approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly...
Further information
Related condition support groups
Migraine Prevention, Migraine Prophylaxis